BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8924058)

  • 21. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
    Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
    Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
    McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
    J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of haemodynamic stabilisation and beta blockade on ventricular fibrillation threshold in coronary artery ligated pigs.
    Muller CA; Kralios AC
    Cardiovasc Res; 1993 Feb; 27(2):274-8. PubMed ID: 8097133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion.
    Lucchesi BR; Hoff PT; Tamura Y
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S34-9. PubMed ID: 16296706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart.
    Ovize M; Aupetit JF; Rioufol G; Loufoua J; André-Fouët X; Minaire Y; Faucon G
    Am J Physiol; 1995 Jul; 269(1 Pt 2):H72-9. PubMed ID: 7631877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart.
    Aupetit JF; Timour Q; Loufoua-Moundanga J; Barral-Cadière L; Lopez M; Freysz M; Faucon G
    J Cardiovasc Pharmacol; 1995 May; 25(5):810-6. PubMed ID: 7630159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular fibrillation and shortening, alternans and after-depolarizations of epicardial monophasic action potentials during coronary occlusion and reperfusion: effect of repetition of ischemia.
    Ito S; Miyazaki T; Miyoshi S; Furukawa Y; Takagi S; Moritani K; Mitamura H; Ogawa S
    Jpn Circ J; 1999 Mar; 63(3):201-8. PubMed ID: 10201622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
    Becker BF; Möbert J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimetazidine protective effect against ischemia-induced susceptibility to ventricular fibrillation in pigs.
    Vaillant F; Tsibiribi P; Bricca G; Bui-Xuan B; Bescond-Jacquet A; Tabib A; Descotes J; Timour Q
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):29-36. PubMed ID: 18157622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
    Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
    Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amlodipine and perindoprilate on the structure and function of mitochondria in ventricular cardiomyocytes during ischemia-reperfusion in the pig.
    Mamou Z; Chahine M; Rhondali O; Dehina L; Chevalier P; Descotes J; Bui-Xuan B; Romestaing C; Timour Q
    Fundam Clin Pharmacol; 2015 Feb; 29(1):21-30. PubMed ID: 24588464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
    Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Correlation with improvement of ventricular conduction and early arrhythmias in the dog.
    Clusin WT; Buchbinder M; Ellis AK; Kernoff RS; Giacomini JC; Harrison DC
    Circ Res; 1984 Jan; 54(1):10-20. PubMed ID: 6692497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation.
    Billman GE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1334-42. PubMed ID: 2467981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
    Hoff PT; Tamura Y; Lucchesi BR
    Am J Cardiol; 1989 Nov; 64(17):101I-115I discussion 115I-116I. PubMed ID: 2530882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
    Roux S; Bühler M; Clozel JP
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.